Salveen Richter
Stock Analyst at Roth Capital
(3.00)
# 1,396
Out of 4,944 analysts
194
Total ratings
39.09%
Success rate
1.06%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FDMT 4D Molecular Therapeutics | Maintains: Buy | $44 → $38 | $6.58 | +477.51% | 5 | Aug 12, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Neutral | $10 → $19 | $19.71 | -3.60% | 6 | Aug 7, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Sell | $15 → $17 | $25.24 | -32.65% | 9 | Aug 7, 2025 | |
| ELVN Enliven Therapeutics | Initiates: Buy | $37 | $19.76 | +87.25% | 1 | Jun 16, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Neutral | $53 → $47 | $58.59 | -19.78% | 4 | May 8, 2025 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $15 → $13 | $10.06 | +29.22% | 3 | May 8, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $124 → $104 | $57.79 | +79.96% | 1 | May 5, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $37 → $41 | $27.48 | +49.20% | 2 | May 2, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Neutral | $12 → $9 | $7.22 | +24.65% | 2 | May 2, 2025 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $9 → $10 | $13.14 | -23.90% | 11 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $917 → $804 | $559.40 | +43.73% | 11 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $219 → $197 | $133.91 | +47.11% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $36 → $32 | $26.13 | +22.46% | 8 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $3.52 | +412.09% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $96 | $119.63 | -19.75% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $99 → $51 | $26.68 | +91.15% | 10 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $14.37 | +178.36% | 5 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $12 | $11.14 | +7.72% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $20 | $14.76 | +35.50% | 7 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $63 → $70 | $85.11 | -17.75% | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $198 → $370 | $434.72 | -14.89% | 5 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $67 → $76 | $28.93 | +162.70% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $33 → $37 | $42.52 | -12.98% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $33 → $53 | $36.27 | +46.13% | 9 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $288.18 | +21.45% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $393.45 | +42.08% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $17.35 | -71.18% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $1.05 | +2,866.51% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $285.36 | -21.15% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $3.75 | +487.45% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $10.56 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $4.47 | +571.14% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $5.66 | +59.15% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $3.08 | -2.44% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $3.26 | +84.33% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $60.94 | -29.44% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $2.76 | -27.40% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $12.02 | +731.95% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $560 → $600 | $6.29 | +9,438.95% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $100.82 | -50.41% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $19.62 | +129.36% | 1 | Mar 17, 2020 |
4D Molecular Therapeutics
Aug 12, 2025
Maintains: Buy
Price Target: $44 → $38
Current: $6.58
Upside: +477.51%
Sarepta Therapeutics
Aug 7, 2025
Maintains: Neutral
Price Target: $10 → $19
Current: $19.71
Upside: -3.60%
ACADIA Pharmaceuticals
Aug 7, 2025
Maintains: Sell
Price Target: $15 → $17
Current: $25.24
Upside: -32.65%
Enliven Therapeutics
Jun 16, 2025
Initiates: Buy
Price Target: $37
Current: $19.76
Upside: +87.25%
CRISPR Therapeutics AG
May 8, 2025
Maintains: Neutral
Price Target: $53 → $47
Current: $58.59
Upside: -19.78%
Arcus Biosciences
May 8, 2025
Maintains: Neutral
Price Target: $15 → $13
Current: $10.06
Upside: +29.22%
BioMarin Pharmaceutical
May 5, 2025
Maintains: Buy
Price Target: $124 → $104
Current: $57.79
Upside: +79.96%
Summit Therapeutics
May 2, 2025
Maintains: Buy
Price Target: $37 → $41
Current: $27.48
Upside: +49.20%
Amicus Therapeutics
May 2, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $7.22
Upside: +24.65%
Adaptive Biotechnologies
May 2, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $13.14
Upside: -23.90%
Apr 30, 2025
Maintains: Buy
Price Target: $917 → $804
Current: $559.40
Upside: +43.73%
Apr 23, 2025
Maintains: Buy
Price Target: $219 → $197
Current: $133.91
Upside: +47.11%
Mar 3, 2025
Maintains: Neutral
Price Target: $36 → $32
Current: $26.13
Upside: +22.46%
Feb 27, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $3.52
Upside: +412.09%
Feb 12, 2025
Maintains: Neutral
Price Target: $85 → $96
Current: $119.63
Upside: -19.75%
Jan 29, 2025
Downgrades: Neutral
Price Target: $99 → $51
Current: $26.68
Upside: +91.15%
Jan 28, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $14.37
Upside: +178.36%
Jan 14, 2025
Maintains: Neutral
Price Target: $20 → $12
Current: $11.14
Upside: +7.72%
Dec 12, 2024
Maintains: Neutral
Price Target: $9 → $20
Current: $14.76
Upside: +35.50%
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $85.11
Upside: -17.75%
Aug 16, 2024
Upgrades: Buy
Price Target: $198 → $370
Current: $434.72
Upside: -14.89%
Aug 2, 2024
Maintains: Buy
Price Target: $67 → $76
Current: $28.93
Upside: +162.70%
Aug 2, 2024
Maintains: Sell
Price Target: $33 → $37
Current: $42.52
Upside: -12.98%
Jun 4, 2024
Maintains: Neutral
Price Target: $33 → $53
Current: $36.27
Upside: +46.13%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $288.18
Upside: +21.45%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $393.45
Upside: +42.08%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $17.35
Upside: -71.18%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $1.05
Upside: +2,866.51%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $285.36
Upside: -21.15%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $3.75
Upside: +487.45%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $10.56
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $4.47
Upside: +571.14%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $5.66
Upside: +59.15%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $3.08
Upside: -2.44%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $3.26
Upside: +84.33%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $60.94
Upside: -29.44%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $2.76
Upside: -27.40%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $12.02
Upside: +731.95%
Mar 4, 2021
Upgrades: Buy
Price Target: $560 → $600
Current: $6.29
Upside: +9,438.95%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $100.82
Upside: -50.41%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $19.62
Upside: +129.36%